J&J BioAdvance® is more than a support program. Our mission is to be a partner to patients and to meet patient support needs with:
Agility:
A program thoughtfully designed to be rapid, reliable, easy to navigate, and within reach.
Experience:
Trust our decades of navigating patient support needs.
Commitment:
A promise to continually evolve, be ready for today, and plan for what's next.
Our service offerings
support
*Patients will be able to choose their dispensing pharmacy.
Built on experience
25yearsof patient support program experience
For over 25 years,
J&J BioAdvance® has built programs rooted in commitment, supporting patients across Canada while adapting to new treatments and evolving needs in healthcare support.

200,000patientsacross all products across Canada
200,000 patients
across Canada have
received support through J&J BioAdvance®.*

9,400HCPs
More than
9,400 Canadian
healthcare professionals
have had patients enrolled
in J&J BioAdvance®.*
* Clinical significance unknown.
Supported products
J&J BioAdvance® supports a wide range of products and conditions across the Johnson & Johnson Innovative Medicine portfolio.
Products currently supported include:
- AKEEGA®
- OPSUMIT®
- DARZALEX® SC
- TALVEY™
- BALVERSA®
- OPSYNVI®
- EPREX®
- TECVAYLI®
- CARIPUL®
- REMICADE®
- ERLEADA®
- TRACLEER®
- CARVYKTI®
- RYBREVANT®
- IMBRUVICA®
- TREMFYA®/
TREMFYA® IV - CONCERTA®
- SIMPONI®/
SIMPONI® IV - INVOKAMET®
- UPTRAVI®
- DARZALEX®
- STELARA®/
STELARA® IV - INVOKANA®
- ZYTIGA®
This site is open to the general public. If you have questions, don't see a medication listed above, or need additional information or support, please see our contact details below.
IV=intravenous; SC=subcutaneous.
Contact us
Interested in learning more about J&J BioAdvance® and all our associated services? Contact us at 1-800-387-8781



